share_log

メディシノバなどが引き続きランクイン、ALS(筋萎縮性側索硬化症)対象の治験開始へ

美第奇新星生物技术等继续跻身榜单,开始进行ALS(肌萎缩侧索硬化症)的临床试验

Fisco日本 ·  09/23 21:36

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发